Cellosaurus logo
expasy logo

Cellosaurus M229 R8 (CVCL_EI89)

[Text][XML][JSON]
Cell line name M229 R8
Accession CVCL_EI89
Resource Identification Initiative To cite this cell line use: M229 R8 (RRID:CVCL_EI89)
Comments Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
Sequence variations
  • Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_D748 (M229)
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=21107323; DOI=10.1038/nature09626; PMCID=PMC3143360
Ramin Nazarian, Hu-Bing Shi, Qi Wang, Xiang-Ju Kong, Richard C. Koya, Hane Lee, Zu-Gen Chen, Mi-Kyung Lee, Narsis Attar, Hooman Sazegar, Thinle Chodon ...Show all 16 authors... , Stanley F. Nelson, Grant A. McArthur, Jeffrey Alan Sosman, Antoni Ribas, Roger S. Lo; Show fewer authors
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Nature 468:973-977(2010)

Cross-references
Cell line databases/resources cancercelllines; CVCL_EI89
Encyclopedic resources Wikidata; Q54903540
Polymorphism and mutation databases Cosmic; 1545608
Entry history
Entry creation26-Sep-2016
Last entry update19-Dec-2024
Version number11